Clinical Trial Update: Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Gleolan (5-aminolevulinic acid hydrochloride) for fluorescence-guided visualization during surgery for newly diagnosed or recurrent men…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• Gleolan (5-aminolevulinic acid hydrochloride)

Snippet

Sponsor: NX Development Corp | Conditions: Meningioma | Phase 3 | Status: COMPLETED